GENEVA, Aug. 25 -- XBRANE BIOPHARMA AB (Scheeles vag 5SE-17165 Solna) filed a patent application (PCT/SE2025/050130) for "STABLE ANTIBODY FORMULATION FOR INTRAVENOUS USE COMPRISING NIVOLUMAB, HISTIDINE, SUCROSE, POLYSORBATE AND METHIONINE" on Feb 16, 2025. With publication no. WO/2025/174319, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RISVEDEN, Klas (Plommonstigen 1277143 Ludvika), GALLAGHER, Mark (Eva Bonniers Gata 812954 Hagersten), STEVENSON, Joanne (Amerikagatan 4615134 Sodertalje), EDEBRINK, Per (Snoilskyvagen 8...